Добірка наукової літератури з теми "Lungs Immunology"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Lungs Immunology".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Lungs Immunology"
Wilkes, D. S., K. M. Heidler, L. K. Bowen, W. M. Quinlan, N. A. Doyle, O. W. Cummings, and C. M. Doerschuk. "Allogeneic bronchoalveolar lavage cells induce the histology of acute lung allograft rejection, and deposition of IgG2a in recipient murine lungs." Journal of Immunology 155, no. 5 (September 1, 1995): 2775–83. http://dx.doi.org/10.4049/jimmunol.155.5.2775.
Повний текст джерелаpolikepahad, sumanth, Jad El-Daye, Arash Naghavi, Jonathan Miller, Preethi Gunaratne, and David Brian Corry. "Lung RNA profiling suggests an essential role for micro RNAs in regulating allergic lung disease (91.9)." Journal of Immunology 178, no. 1_Supplement (April 1, 2007): S161. http://dx.doi.org/10.4049/jimmunol.178.supp.91.9.
Повний текст джерелаKulkarni, Hrishikesh Satish, Fuyi Liao, Lina Ma, Xiaobo Wu, Daniel Kreisel, John P. Atkinson, and Andrew E. Gelman. "C3 expression by lung transplants reduces alloimmune-mediated injury." Journal of Immunology 202, no. 1_Supplement (May 1, 2019): 69.21. http://dx.doi.org/10.4049/jimmunol.202.supp.69.21.
Повний текст джерелаBarker, Kimberly A., Anukul T. Shenoy, Nicole Stauffer-Smith, Emad Isam Arafa, Carolina Lyon de Ana, Alex Barron, Fumiaki Aihara, et al. "Lung resident memory B cells are a common and functionally significant component of lung adaptive immunity." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 85.8. http://dx.doi.org/10.4049/jimmunol.204.supp.85.8.
Повний текст джерелаNishinakamura, R., R. Wiler, U. Dirksen, Y. Morikawa, K. Arai, A. Miyajima, S. Burdach, and R. Murray. "The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation." Journal of Experimental Medicine 183, no. 6 (June 1, 1996): 2657–62. http://dx.doi.org/10.1084/jem.183.6.2657.
Повний текст джерелаLund, Sean J., Kathryn A. Patras, Jacqueline M. Kimmey, Asami Yamamura, Gilberto Hernandez, Omar Lakhdari, Alyssa M. McCoy, Victor Nizet, and Lawrence S. Prince. "Polysaccharide capsule allows Group B Streptococcus to avoid killing in a newborn pneumonia model." Journal of Immunology 200, no. 1_Supplement (May 1, 2018): 117.30. http://dx.doi.org/10.4049/jimmunol.200.supp.117.30.
Повний текст джерелаPark, Juwon, Christina Lee та Michelle D. Tallquist. "PDGFRα ablation leads to alteration of ECM and immune cell composition in the lung". Journal of Immunology 204, № 1_Supplement (1 травня 2020): 74.20. http://dx.doi.org/10.4049/jimmunol.204.supp.74.20.
Повний текст джерелаLorenzo, Erica, Jacob Hopkins, Julie Lefebvre, and Laura Haynes. "Vaccination does not protect aged mice from influenza-induced lung inflammation (VAC9P.1062)." Journal of Immunology 194, no. 1_Supplement (May 1, 2015): 145.2. http://dx.doi.org/10.4049/jimmunol.194.supp.145.2.
Повний текст джерелаChapoval, Svetlana P., Ann E. Kelly-Welch, Elizabeth Smith, and Achsah D. Keegan. "Complex role of STAT6 in allergic airway inflammation (39.11)." Journal of Immunology 178, no. 1_Supplement (April 1, 2007): S27. http://dx.doi.org/10.4049/jimmunol.178.supp.39.11.
Повний текст джерелаSingh, Ram Raj, and Isela Valera. "Plasmacytoid dendritic cells contribute to pro-inflammatory and pro-fibrotic milieu in lung fibrosis." Journal of Immunology 202, no. 1_Supplement (May 1, 2019): 182.76. http://dx.doi.org/10.4049/jimmunol.202.supp.182.76.
Повний текст джерелаДисертації з теми "Lungs Immunology"
Lemaitre, Philippe. "Early role of IL-17 and calcineurin inhibitor-mediated Th2- and Th17-polarization of chronic trachea allograft rejection pathways." Doctoral thesis, Universite Libre de Bruxelles, 2014. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/209243.
Повний текст джерелаWe first demonstrated that interleukin-17 contributes to inflammatory lesions in the early phase post-transplantation. Interleukin-17 was found to be produced by &61543;&61540;+ T cells and CD4+ T cells infiltrating the graft and interleukin-17 neutralization significantly reduced the development of epithelial lesions together with inhibition of interleukin-6 and heat-shock-protein 70 gene transcription.
We then investigated the contribution of interleukin-17 to obliterative airway disease. Although interleukin-17 did not play a dominant role in absence of immunosuppression, it was found to contribute to airway pathology in animals receiving cyclosporin A. Under this treatment, we first observed dramatic changes in the composition of the lymphocyte populations infiltrating the graft: the numbers of CD8+ T cells producing interferon-&61543; and type 1 CD4+ T cells were dramatically decreased while the numbers of type 17, and also type 2 CD4+ T cells were unaffected. The pathological relevance of these findings was first demonstrated by the prolongation of graft survival afforded by the depletion of CD4+ T cells in cyclosporin A-treated animals. Furthermore, graft rejection was also delayed in mice genetically deficient in either interleukin-17 or interleukin-4, providing evidence that type 17 and type 2 CD4+ T cells actively contribute to graft rejection in cyclosporin A-treated recipients. On the other hand, parallel experiments in interferon-&61543;-deficient mice revealed that interferon-&
Doctorat en Sciences médicales
info:eu-repo/semantics/nonPublished
Vanderstocken, Gilles. "Caractérisation du rôle des nucléotides extracellulaires et du récepteur purinergique P2Y2 dans la physiopathologie des maladies pulmonaires inflammatoires." Doctoral thesis, Universite Libre de Bruxelles, 2012. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/209591.
Повний текст джерелаhealth problem. As a consequence, investigating the immune mechanisms that contribute to
the pathogenesis of these diseases is essential to identify candidate targets for the
development of new therapeutic drugs. Furthermore, over the past 20 years, the growing awareness
that purinergic signalling events shape the immune and inflammatory responses to infection and
allergic reactions warranted the development of animal models to assess their importance in vivo in
acute lung injury and chronic airway diseases. The field of purinergic inflammation formulated the
unifying concept that ATP is released as a «danger signal» to induce inflammatory responses upon
binding purinergic receptors.
According to these elements, we began in 2007 to evaluate lung inflammation in mice deficient for
the P2Y2 purinergic receptor in TH2 and TH1 models. The most convincing evidence that the P2Y2
receptor is engaged during alarm situations comes from studies related to cystic fibrosis and asthma.
Indeed, chronic respiratory diseases are commonly associated with elevated airway ATP
concentrations, as reported in cystic fibrosis, but also in idiopathic pulmonary fibrosis and chronic
obstructive pulmonary disease (COPD) patients, and they are raised by allergens in asthmatic
patients.
First, we demonstrated a significant role of the P2Y2R in a TH2-ovalbumin(OVA)-induced asthma
model. We observed that eosinophil accumulation, a distinctive feature of lung allergic inflammation,
was defective in OVA-treated P2Y2-deficient mice compared with OVA-treated wild type animals.
Interestingly, the upregulation of VCAM-1 was lower on lung endothelial cells of OVA-treated P2Y2
knockout mice compared with OVA-treated wild type animals. Adhesion assays demonstrated that
the action of UTP on leukocyte adhesion through the regulation of endothelial VCAM-1 was
abolished in P2Y2-deficient lung endothelial cells. Additionally, the level of soluble VCAM-1, reported
as an inducer of eosinophil chemotaxis, was strongly reduced in the bronchoalveolar lavage fluid of
P2Y2-deficient mice.
Secondly, we studied the consequences of P2Y2R loss in lung inflammation initiated after pneumonia
virus of mice (PVM) infection in collaboration with the group of Pr. Daniel Desmecht (ULg). We
demonstrated here that P2Y2
-/-
mice display a severe increase in morbidity and mortality rate in
response to PVM. Lower survival of P2Y2
-/-
mice was not correlated with excessive inflammation
despite the higher level of neutrophil recruiters in their broncho-alveolar fluids. Interestingly, we
observed lower numbers of dendritic cells, CD4
+
T cells and CD8
+
T cells in P2Y2
-/-
mice compared to
P2Y2
+/+
infected lungs. Lower level of IL-12 and higher level of IL-6 in broncho-alveolar fluid support
an inhibition of Th1 response in P2Y2
-/-
mice. Quantification of DC recruiter expression revealed
comparable IP-10 and MIP-3&
Doctorat en Sciences biomédicales et pharmaceutiques
info:eu-repo/semantics/nonPublished
Fallata, Ghaith Mohammed. "Association of gut luminal metabolites and allergic responses." Wright State University / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=wright1515185113264117.
Повний текст джерелаTodd, Anthony. "The immunology of extrinsic allergic alveolitis : with reference to bird breeders' lung." Thesis, University of Newcastle Upon Tyne, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.287418.
Повний текст джерелаRamis, Cabrer Daniel 1993. "From chronic obstructive pulmonary disease to lung cancer : an immunologic approach." Doctoral thesis, Universitat Pompeu Fabra, 2019. http://hdl.handle.net/10803/667310.
Повний текст джерелаIt is well established that a subset of cancer patients debuts with immune infiltrates, which organize into aggregates in the tumor niche and its vicinity. These lymphoid structures develop in response to inflammatory stimuli through a tightly regulated process. Besides the prognostic value of TLSs, they also may represent a novel avenue for therapeutic strategies, but it is currently still in its early stages. In contrast with the immune activator role of TLSs, in certain cancers, its effect may point towards tumor progression as a consequence of highly tumor-mediated immunosuppressive conditions present in the tumor niche. Preliminary data provided by the current investigation suggests that a differential immune profile may be present between LC patients and LC patients underlying COPD. This fact could present a potential impact in the prognosis and therapy of these patients. Moreover, crucial markers targeting different signaling pathways involved with oxidative stress, apoptosis, and autophagy were found to be overexpressed in response to immunomodulators administration in the current thesis. These data puts into manifest the interest of additional immunity-related mechanisms that could be targeted in order to assist immunity against cancer.
Larsson, Emelie Olivia. "Immune to brain communication in allergic lung inflammation." Thesis, University of Southampton, 2013. https://eprints.soton.ac.uk/355709/.
Повний текст джерелаWhite, Anna-Marie. "The role of tumour necrosis factor α in lung inflammation". Thesis, University of Bath, 1996. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.362198.
Повний текст джерелаSingh, Ravinder. "The role of Death Receptor 3 in allergic lung inflammation." Thesis, Cardiff University, 2014. http://orca.cf.ac.uk/56963/.
Повний текст джерелаArko-Mensah, John. "Mycobacterial infection: Immune evasion, host susceptibility and immunological markers of diagnostic importance." Doctoral thesis, Stockholm University, Wenner-Gren Institute for Experimental Biology, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-8208.
Повний текст джерелаIIn the first study, we investigated the functional implications of prolonged TLR signalling on IFN-γ mediated killing of mycobacteria by murine macrophages in vitro. TLR2, but not TLR4 ligation interfered with IFN-γ mediated killing of mycobacteria in macrophages. In terms of mechanisms, neither TNF nor nitric oxide (NO) production was significantly affected, and the refractoriness induced could be reversed with increasing amounts of IFN-γ In the second study, we aimed to identify immunological markers of diagnostic importance in both the respiratory tract and serum during pulmonary mycobacterial infection in mice. We found that increased levels of immunological markers in the respiratory tract, but not serum, correlated better with active mycobacterial infection in the lungs, suggesting that the immune response in the respiratory tract is more reflective of the infection status and pathology than the systemic response. Finally, we investigated the level and nature of immune responses to pulmonary mycobacterial infection in BALB/c and C57BL/6 mice, two mouse strains known to exhibit different susceptibilities to infection with several intracellular pathogens, including mycobacteria. We showed that increased susceptibility of BALB/c mice to early mycobacterial infection was associated with reduced Th1 immune responses, and increased sTNFR secretion in the lung. Moreover, BALB/c mice recruited fewer monocytes/macrophages to the lung, and although IFN-γ stimulation of infected bone marrow derived macrophages in both mouse strains resulted in induction of antimycobacterial activity, BALB/c mice had a reduced capacity to kill ingested bacteria. The work presented in this thesis provide further insight into the mechanisms involved in the host-pathogen interaction; from persistence, to the immunological processes induced by the pathogen, to susceptibility of the host to infection.
Hosker, Harold Stephen Ronald. "Alveolar macrophage and blood monocyte function in small cell lung cancer." Thesis, University of Newcastle Upon Tyne, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.241364.
Повний текст джерелаКниги з теми "Lungs Immunology"
1929-, Staub Norman C., ed. The Pulmonary intravascular macrophage. Mount Kisco, NY: Futura Pub. Co., 1989.
Знайти повний текст джерелаA, Stockley Robert, ed. Pulmonary defences. Chichester: J. Wiley, 1997.
Знайти повний текст джерелаShennib, Hani. Immunology of the lung allograft. New York: Springer-Verlag, 1995.
Знайти повний текст джерелаL, Kradin Richard, and Robinson Bruce W. S, eds. Immunopathology of lung disease. Boston: Butterworth-Heinemann, 1996.
Знайти повний текст джерелаL, Rose Marlene, and Yacoub Magdi, eds. Immunology of heart and lung transplantation. London: Edward Arnold, 1993.
Знайти повний текст джерела1941-, Lipscomb Mary F., and Russell S. W, eds. Lung macrophages and dendritic cells in health and disease. New York: M. Dekker, 1997.
Знайти повний текст джерела1946-, Barnes Peter J., and Stockley Robert A, eds. Molecular biology of lung disease. Oxford: Blackwell Scientific Publications, 1994.
Знайти повний текст джерелаHerman, Chmel, Bendinelli Mauro, and Friedman Herman 1931-, eds. Pulmonary infections and immunity. New York: Plenum Press, 1994.
Знайти повний текст джерелаWilliams, Marc A. Allergens and respiratory pollutants: The role of innate immunity. Oxford: Biohealthcare, 2011.
Знайти повний текст джерелаPhilip, Witorsch, and Spagnolo Samuel V, eds. Air pollution and lung disease in adults. Boca Raton, Fla: CRC Press, 1994.
Знайти повний текст джерелаЧастини книг з теми "Lungs Immunology"
Kurup, Viswanath P., and Alan P. Knutsen. "Fungal Hypersensitivity in the Lungs." In Fungal Immunology, 241–64. Boston, MA: Springer US, 2005. http://dx.doi.org/10.1007/0-387-25445-5_12.
Повний текст джерелаGarvy, Beth A., and Francis Gigliotti. "Antibody-Mediated Immunity to Pneumocystis in the Lungs." In Fungal Immunology, 291–302. Boston, MA: Springer US, 2005. http://dx.doi.org/10.1007/0-387-25445-5_14.
Повний текст джерелаKawakami, Kazuyoshi. "Innate Immunity in the Lungs to Cryptococcal Infection." In Fungal Immunology, 135–55. Boston, MA: Springer US, 2005. http://dx.doi.org/10.1007/0-387-25445-5_7.
Повний текст джерелаFeldmesser, Marta, and Arturo Casadevall. "Antibody-Mediated Immunity to Fungi in the Lungs." In Fungal Immunology, 181–200. Boston, MA: Springer US, 2005. http://dx.doi.org/10.1007/0-387-25445-5_9.
Повний текст джерелаRomani, Luigina, and Paolo Puccetti. "Immune Regulation and Tolerance to Fungi in the Lungs and Skin." In Chemical Immunology and Allergy, 124–37. Basel: KARGER, 2008. http://dx.doi.org/10.1159/000154957.
Повний текст джерелаGimferrer, Idoia, and Karen A. Nelson. "Immunology in Lung Transplantation." In Lung Transplantation, 139–60. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-91184-7_9.
Повний текст джерелаZumla, Alimuddin, Sarah Rowland-Jones, and Andrew McMichael. "Lung Immunology and HIV." In AIDS and Respiratory Medicine, 15–40. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4899-3446-8_2.
Повний текст джерелаDorn, Joshua M., Tamara C. Pozos, and Roshini S. Abraham. "Lung Abscess." In Pediatric Immunology, 339–41. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-21262-9_66.
Повний текст джерелаGamondès, Delphine, and Didier Revel. "Immunologic Lung Disease." In Integrated Cardiothoracic Imaging with MDCT, 197–202. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-72387-5_12.
Повний текст джерелаBoghossian, Shahe. "Immunotherapy of Lung Tumors." In Cancer Immunology, 363–82. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-46410-6_19.
Повний текст джерелаТези доповідей конференцій з теми "Lungs Immunology"
Halvorsen, Elizabeth C., S. Elizabeth Franks, Brennan J. Wadsworth, Bryant T. Harbourne, Rachel A. Cederberg, Catherine A. Steer, Itziar Martinez-Gonzalez, Jack Calder, William W. Lockwood, and Kevin L. Bennewith. "Abstract A50: Interleukin-33 increases ST2+ regulatory T cells and promotes metastatic tumor growth in the lungs in an amphiregulin-dependent manner." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 27-30, 2018; Miami Beach, FL. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm18-a50.
Повний текст джерелаWang, Lei, Charlotte E. Pelgrim, Lucía N. Peralta Marzal, Stephanie Korver, Ingrid Van Ark, Thea Leusink-Muis, Ardy Van Helvoort, et al. "Mucosal immunology of the gut and lung in a cigarette smoke-induced murine model for COPD: the lung-gut axis." In ERS Lung Science Conference 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/23120541.lsc-2022.53.
Повний текст джерелаRoncaglioni, M. C., A. Falanga, A. P. Bolognese Dalessandro, B. Casali, and M. B. Donti. "ENZYMATIC AND IMMUNOLOGIC CHARACTERIZATION OF A CYSTEINE PROTEINASE PROCOAGULANT IN SEVERAL MURINE METASTASIZING TUMO." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643663.
Повний текст джерелаSchmidt, Leah M., Oanh Tran, Shannon Oda, Quintin Inman, Sasha Tan, Cody Jenkins, and Philip Greenberg. "Abstract PO079: Effects of the lung tumor microenvironment on T cell therapy." In Abstracts: AACR Virtual Special Conference: Tumor Immunology and Immunotherapy; October 19-20, 2020. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/2326-6074.tumimm20-po079.
Повний текст джерелаMaestre, Danay, Ryan D. Huff, Carley Schwartz, Anette K. Bølling, and Christopher Carlsten. "Di-butyl phthalate (DBP) augments allergen-induced lung function decline and alters lower airway innate immunology in crossover human study." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa1992.
Повний текст джерелаCarlsten, C., D. Maestre-Batlle, R. D. Huff, C. Schwartz, and A. K. Bølling. "Di-butyl Phthalate (DBP) Worsens Allergen-Induced Lung Function Decline and Alters Lower Airway Innate Immunology in Crossover Human Study." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1163.
Повний текст джерелаHung, Jung-Jyh. "Abstract PO061: Prognostic significance of S100A2 expression in patients with resected lung adenocarcinoma." In Abstracts: AACR Virtual Special Conference: Tumor Immunology and Immunotherapy; October 19-20, 2020. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/2326-6074.tumimm20-po061.
Повний текст джерелаLau, Denise, Michelle Stein, Jason Perera, Madhavi Kannan, and Aly Khan. "Abstract PR12: Genomic landscape of immunotherapy resistance in lung cancer." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 17-20, 2019; Boston, MA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm19-pr12.
Повний текст джерелаZhao, Chen, Weizhe Li, Chengcheng Jin, and Ronald N. Germain. "Abstract A62: Directly visualizing interactions between lung microbiota, tissue-resident immune cells and tumor cells in a genetically engineered lung adenocarcinoma mouse model." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 27-30, 2018; Miami Beach, FL. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm18-a62.
Повний текст джерелаJin, Chengcheng, Chen Zhao, Georgia Lagoudas, Arjun Bhutkar, Bo Hu та Tyler Jacks. "Abstract A63: Commensal microbiota promote lung tumorigenesis via γδ T cells". У Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 27-30, 2018; Miami Beach, FL. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm18-a63.
Повний текст джерела